West Pharmaceutical Services, Inc. (NYSE: WST)

West Pharmaceutical Services Expands Injectable Drug Portfolio with FDA Cleared Vial2Bag Advanced 13mm Admixture Device

EXTON, PA — In a move that strengthens its position as a global leader in innovative solutions for injectable drug administration systems, West Pharmaceutical Services, Inc. (NYSE: WST) recently announced …

West Pharmaceutical Services Expands Injectable Drug Portfolio with FDA Cleared Vial2Bag Advanced 13mm Admixture Device Read More

West Pharmaceutical Services, Inc. (NYSE: WST)

West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance, Declares Fourth-Quarter 2023 Dividend

EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) announced its financial results for the third-quarter 2023, updated full-year 2023 financial guidance and declared a fourth-quarter 2023 dividend.

West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance, Declares Fourth-Quarter 2023 Dividend Read More